Dendritic cell activation and maturation pathway

The dendritic cell activation and maturation pathway encompasses a set of signaling events initiated by external stimuli, such as pathogen-associated molecular patterns via Toll-like receptors (TLRs), leading to a cellular state transition from an immature, antigen-capturing phenotype to a mature, antigen-presenting cell capable of priming and polarizing T cells. Key canonical signaling axes include NF-κB, MAP kinase (e.g., p38, JNK, ERK), and interferon regulatory factors (IRFs). These regulate processes like upregulation of MHC and costimulatory molecules, cytokine production, survival, and migration of dendritic cells. This pathway plays central roles in the balance of immunity and tolerance and is a key node for therapeutic modulation in vaccines and immunotherapy. Note: This entry, as worded, is too broad for most structured drug target repositories, which require specific canonical targets (proteins, enzymes, receptors). The maturation pathway comprises multiple protein targets (e.g., TLRs, NF-κB, ERKs), rather that being a single target itself. For purposes requiring discrete, druggable targets, it would be preferable to specify an individual molecule (e.g., "Toll-like receptor 4" or "NF-κB") rather than the entire cellular signaling pathway.

Other names

Dendritic cell maturation pathwayDC activation pathwayDendritic cell activation signaling

Immunomodulation by activating or inhibiting dendritic cell signaling (e.g., TLR agonists trigger DC activation and maturation; immunosuppressants like corticosteroids suppress it)